Van Miegroet H - Search Results

1

Are nitrogen-fertilized forest soils sinks or sources of carbon?

Van Miegroet H, Jandl R. Van Miegroet H, et al. Environ Monit Assess. 2007 May;128(1-3):121-31. doi: 10.1007/s10661-006-9410-7. Epub 2006 Dec 16. Environ Monit Assess. 2007. PMID: 17180428

2

Is there synchronicity in nitrogen input and output fluxes at the Noland Divide Watershed, a small N-saturated forested catchment in the Great Smoky Mountains National Park?

Van Miegroet H, Creed IF, Nicholas NS, Tarboton DG, Webster KL, Shubzda J, Robinson B, Smoot J, Johnson DW, Lindberg SE, Lovett G, Nodvin S, Moore S. Van Miegroet H, et al. ScientificWorldJournal. 2001 Nov 22;1 Suppl 2:480-92. doi: 10.1100/tsw.2001.384. ScientificWorldJournal. 2001. PMID: 12805804 Free PMC article.

3

Contribution of TARDBP to Alzheimer's disease genetic etiology.

Brouwers N, Bettens K, Gijselinck I, Engelborghs S, Pickut BA, Van Miegroet H, Montoya AG, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Brouwers N, et al. Among authors: van miegroet h. J Alzheimers Dis. 2010;21(2):423-30. doi: 10.3233/JAD-2010-100198. J Alzheimers Dis. 2010. PMID: 20555136

4

Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association.

Bettens K, Brouwers N, Van Miegroet H, Gil A, Engelborghs S, De Deyn PP, Vandenberghe R, Van Broeckhoven C, Sleegers K. Bettens K, et al. Among authors: van miegroet h. J Alzheimers Dis. 2010;19(4):1169-75. doi: 10.3233/JAD-2010-1310. J Alzheimers Dis. 2010. PMID: 20308783

5

Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen.

Lierman E, Van Miegroet H, Beullens E, Cools J. Lierman E, et al. Among authors: van miegroet h. Haematologica. 2009 Oct;94(10):1440-4. doi: 10.3324/haematol.2009.007328. Haematologica. 2009. PMID: 19794087 Free PMC article.

6

APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.

Bettens K, Brouwers N, Engelborghs S, Van Miegroet H, De Deyn PP, Theuns J, Sleegers K, Van Broeckhoven C. Bettens K, et al. Among authors: van miegroet h. Hum Mutat. 2009 Aug;30(8):1207-13. doi: 10.1002/humu.21027. Hum Mutat. 2009. PMID: 19462468

7

No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.

Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. Sleegers K, et al. Among authors: van miegroet h. Hum Mutat. 2009 Apr;30(4):E570-4. doi: 10.1002/humu.20990. Hum Mutat. 2009. PMID: 19191332

8

Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia.

Sleegers K, Bettens K, Brouwers N, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. Sleegers K, et al. Among authors: van miegroet h. Hum Mutat. 2009 Feb;30(2):E338-44. doi: 10.1002/humu.20909. Hum Mutat. 2009. PMID: 18853460

9

The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors.

Lierman E, Lahortiga I, Van Miegroet H, Mentens N, Marynen P, Cools J. Lierman E, et al. Among authors: van miegroet h. Haematologica. 2007 Jan;92(1):27-34. doi: 10.3324/haematol.10692. Haematologica. 2007. PMID: 17229632 Free article.

10

Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant.

Lierman E, Folens C, Stover EH, Mentens N, Van Miegroet H, Scheers W, Boogaerts M, Vandenberghe P, Marynen P, Cools J. Lierman E, et al. Among authors: van miegroet h. Blood. 2006 Aug 15;108(4):1374-6. doi: 10.1182/blood-2006-02-004457. Epub 2006 Apr 27. Blood. 2006. PMID: 16645167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page